These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17009252)

  • 21. Pad test by mail for home evaluation of urinary incontinence.
    Flisser AJ; Figueroa J; Bleustein CB; Panagopoulos G; Blaivas JG
    Neurourol Urodyn; 2004; 23(2):127-9. PubMed ID: 14983423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are there differences between women with urge predominant and stress predominant mixed urinary incontinence?
    Lewis JB; Ng AV; O'Connor RC; Guralnick ML
    Neurourol Urodyn; 2007; 26(2):204-7. PubMed ID: 17078089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study.
    Tjandra JJ; Chan MK; Yeh CH; Murray-Green C
    Dis Colon Rectum; 2008 May; 51(5):494-502. PubMed ID: 18278532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of sacral nerve stimulation for fecal incontinence.
    Altomare DF; Ratto C; Ganio E; Lolli P; Masin A; Villani RD
    Dis Colon Rectum; 2009 Jan; 52(1):11-7. PubMed ID: 19273950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do pad tests and voiding diaries affect patient willingness to participate in studies of incontinence treatment outcomes?
    Singh M; Bushman W; Clemens JQ
    J Urol; 2004 Jan; 171(1):316-8; discussion 318-9. PubMed ID: 14665904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sacral neuromodulation: long-term experience of one center.
    Elhilali MM; Khaled SM; Kashiwabara T; Elzayat E; Corcos J
    Urology; 2005 Jun; 65(6):1114-7. PubMed ID: 15913732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Objective and quality-of-life outcomes with bone-anchored male bulbourethral sling.
    Gallagher BL; Dwyer NT; Gaynor-Krupnick DM; Latini JM; Kreder KJ
    Urology; 2007 Jun; 69(6):1090-4. PubMed ID: 17572193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery.
    Mahajan ST; Elkadry EA; Kenton KS; Shott S; Brubaker L
    Am J Obstet Gynecol; 2006 Mar; 194(3):722-8. PubMed ID: 16522404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery.
    Sherman ND; Jamison MG; Webster GD; Amundsen CL
    Am J Obstet Gynecol; 2005 Dec; 193(6):2083-7. PubMed ID: 16325620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One year follow-up on the SPARC sling system for the treatment of female urodynamic stress incontinence.
    Primus G
    Int J Urol; 2006 Nov; 13(11):1410-4. PubMed ID: 17083393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sacral nerve stimulation for faecal incontinence: long-term outcome.
    Matzel KE; Lux P; Heuer S; Besendörfer M; Zhang W
    Colorectal Dis; 2009 Jul; 11(6):636-41. PubMed ID: 18727721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sacral nerve stimulation for fecal incontinence: external anal sphincter defect vs. intact anal sphincter.
    Chan MK; Tjandra JJ
    Dis Colon Rectum; 2008 Jul; 51(7):1015-24; discussion 1024-5. PubMed ID: 18484136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register.
    Spinelli M; Bertapelle P; Cappellano F; Zanollo A; Carone R; Catanzaro F; Giardiello G; De Seta F;
    J Urol; 2001 Aug; 166(2):541-5. PubMed ID: 11458063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A statistical comparison of pad numbers versus pad weights in the quantification of urinary incontinence.
    Dylewski DA; Jamison MG; Borawski KM; Sherman ND; Amundsen CL; Webster GD
    Neurourol Urodyn; 2007; 26(1):3-7. PubMed ID: 17080415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised trial of laparoscopic Burch colposuspension versus tension-free vaginal tape: long-term follow up.
    Jelovsek JE; Barber MD; Karram MM; Walters MD; Paraiso MF
    BJOG; 2008 Jan; 115(2):219-25; discussion 225. PubMed ID: 18081602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spiral sling salvage anti-incontinence surgery for women with refractory stress urinary incontinence: surgical outcome and satisfaction determined by patient-driven questionnaires.
    Mourtzinos A; Maher MG; Raz S; Rodríguez LV
    Urology; 2008 Nov; 72(5):1044-8; discussion 1048-50. PubMed ID: 18804264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sacral neuromodulation: cost considerations and clinical benefits.
    Aboseif SR; Kim DH; Rieder JM; Rhee EY; Menefee SA; Kaswick JR; Ree MH
    Urology; 2007 Dec; 70(6):1069-73; discussion 1073-4. PubMed ID: 18158016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sacral neuromodulation in patients with faecal incontinence: results of the first 100 permanent implantations.
    Melenhorst J; Koch SM; Uludag O; van Gemert WG; Baeten CG
    Colorectal Dis; 2007 Oct; 9(8):725-30. PubMed ID: 17509049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.